Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.
about
CIViC databaseClinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsNovel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.Metabolomic heterogeneity of pulmonary arterial hypertensionCharacteristics, clinical outcome, and prognostic significance of IDH mutations in AMLPrognostic significance of IDH1 mutations in acute myeloid leukemia: a meta-analysisTET family proteins: oxidation activity, interacting molecules, and functions in diseases.Back to the origin: reconsidering replication, transcription, epigenetics, and cell cycle control.What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age.Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility.Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight.High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.
P2860
Q27612411-71F4592B-AC7F-4602-B524-C2CBF3364711Q29039802-A16F5415-C838-401C-BE1D-3C2E8EF63D81Q35010433-BCF7D582-C122-4FA4-A794-40D55CFD026EQ35095550-81BAD257-CD8C-4619-B389-F8665725F439Q36181742-9DC9EF0F-EAFF-49EA-9358-1128C8E105F7Q36439908-2B883675-37DA-4989-AA00-A602A40D29B1Q36668364-CC0C911A-A80F-45D8-A5E0-B8E0A0BB8A68Q36796433-6472725C-D5C9-44C0-A987-85BDEC6E75CEQ36832167-F558BFFE-BACD-4C5D-AAF9-ACC24FC4BF98Q36928342-FCB035F4-AF7D-438D-84F7-DB0F6CB93372Q37240701-984B20ED-81C1-4EB9-A200-E73C7255DA3EQ37432049-880C4662-E41B-426D-94BA-3EDA8398C727Q37702702-1F9E270B-8D6A-4D5A-B87A-8A99639E7C13Q38183943-83FC4DB9-8005-4F42-A49A-1958A3E99EE5Q38187680-146D6101-D49A-44FB-B56C-68C62DB49818Q38240563-34A35669-CB15-4E7D-8956-37FDF86EE463Q38703904-F4C19930-9EF2-4973-BB3B-7E33CA228168Q41247181-C6FBF726-C118-4707-92EA-06C58788DD4AQ41670609-65AA21FD-3064-49B0-A0DC-77B372F79466Q42573844-F15F8F88-D5F9-4F0D-9FE4-0B8DF895CB81Q48595265-9C325842-3006-448B-9323-E222F1356A8D
P2860
Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@ast
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@en
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@nl
type
label
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@ast
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@en
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@nl
prefLabel
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@ast
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@en
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@nl
P2093
P2860
P3181
P1433
P1476
Potential application of IDH1 ...... oid leukemia: a meta-analysis.
@en
P2093
Jian-Feng Zhou
Kuang-Guo Zhou
Li-Jun Jiang
Liang Huang
Zhen Shang
P2860
P304
P3181
P356
10.3109/10428194.2012.695359
P577
2012-12-01T00:00:00Z